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Purpose: Radiofrequency ablation (RFA) of the greater saphenous vein (GSV; “closure”) is a relatively new option for
treatment of venous reflux. However, our initial enthusiasm for this minimally invasive technique has been tempered by
our preliminary experience with its potentially lethal complication, deep venous thrombosis (DVT).
Methods: Seventy-three lower extremities were treated in 66 patients with GSV reflux, between April 2003 and February
2004. There were 48 (73%) female patients and 18 (27%) male patients, with ages ranging from 26 to 88 years (mean, 62
 14 years). RFA was combined with stab avulsion of varicosities in 55 (75%) patients and subfascial ligation of
perforator veins in 6 (8%) patients. An ATL HDI 5000 scanner with linear 7-4 MHz probe and the SonoCT feature was
used for GSV mapping and procedure guidance in all procedures. GSV diameter determined the size of the RFA catheter
used. Veins less than 8 mm in diameter were treated with a 6F catheter (n 54); an 8F catheter was used for veins greater
than 8 mm in diameter (n 19). The GSV was cannulated at the knee level. The tip of the catheter was positioned within
1 cm of the origin of the inferior epigastric vein (first GSV tributary). All procedures were carried out according to
manufacturer guidelines.
Results: All patients underwent venous duplex ultrasound scanning 2 to 30 days (mean, 10 6 days) after the procedure.
The duplex scans documented occlusion of the GSV in 70 limbs (96%). In addition, DVT was found in 12 limbs (16%).
Eleven patients (92%) had an extension of the occlusive clot filling the treated proximal GSV segment, with a floating tail
beyond the patent inferior epigastric vein into the common femoral vein. Another patient developed acute occlusive clots
in the calf muscle (gastrocnemius) veins. Eight patients were readmitted and received anticoagulation therapy. Four
patients were treated with enoxaparin on an ambulatory basis. None of these patients had pulmonary embolism. Initially
3 patients with floating common femoral vein clots underwent inferior vena cava filter placement. Of the 19 limbs treated
with the 8F RFA catheter, GSV clot extension developed in 5 (26%), compared with 7 of 54 (13%) limbs treated with the
6F RFA catheter (P  .3). No difference was found between the occurrence of DVT in patients who underwent the
combined procedure (RFA and varicose vein excision) compared with patients who underwent GSV RFA alone (P .7).
No statistically significant differences were found in age or gender of patients with or without postoperative DVT (P 
NS).
Conclusion: Patients who underwent combined GSV RFA and varicose vein excision did not demonstrate a higher
occurrence of postoperative DVT compared with patients who underwent RFA alone. Early postoperative duplex scans
are essential, and should be mandatory in all patients undergoing RFA of the GSV. (J Vasc Surg 2004;40:500-4.)Venous insufficiency is one of the most common prob-
lems in all of medicine.1-5 One of the standard treatments
has been high ligation with proximal stripping of the
greater saphenous vein (GSV).6,7 However, significant
morbidity, dissatisfaction, and rate of recurrence have been
documented with this procedure.8-20
As an alternative, radiofrequency ablation (RFA) of the
GSV (“Closure”) has been introduced as a relatively new
option for treatment of venous reflux. The procedure is
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doi:10.1016/j.jvs.2004.04.032500minimally invasive, simple, associated with decreased pain
and hematomas, and a low incidence of complications.21,22
Therefore the Closure procedure is rapidly gaining popu-
larity. Since the procedure has the promise of improving the
care of many of our patients, we wanted to review our initial
experience.
METHODS
The Closure procedure consists of controlled collagen
denaturization of an incompetent superficial vein to ablate
the venous lumen diameter with radiofrequency-resistive
heating of the vein wall. This is controlled with vein wall
temperature and impedance feedback. A dedicated micro-
processor-controlled bipolar generator and catheter with
collapsible electrodes are introduced percutaneously into
the vein lumen.
High-resolution scanners (full-featured HDI 5000
with SonoCT option) handled by experienced registered
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GSV was punctured at the knee level under ultrasound
guidance (linear 7-4 MHz probe inserted in a sterile cover
with acoustic coupling gel) and a 0.025-inch guide wire
was followed proximally to the common femoral vein. The
introducer sheath was inserted, and the radiofrequency
catheter was placed over the wire to approximately 1 cm
from the first tributary of the GSV under direct ultrasound
visualization. Infiltration over the GSV with tumescence
solution (300 mL of normal saline solution, 50 mL of 1%
lidocaine with 1:100,000 epinephrine, 10 mL of sodium
bicarbonate) under ultrasound guidance was performed to
compress the GSV and protect the skin from thermal
damage.
Our technique for performing RFA of the GSV care-
fully followed all steps suggested by the manufacturer, and
the initial 5 procedures were performed under direct obser-
vation of company representatives. Treatment temperature
of 85°C was maintained during treatment while pulling
back the catheter. Infusion with heparinized saline solution
(5000 U in 500 mL of saline solution) through the catheter
was maintained at a rate of 1 drop per second. The catheter
was withdrawn at a rate of 1 cm/min for the first 3 cm of
the vein length for better seal, and at 2 to 3 cm/min
thereafter. Impedance was kept at more than 150 ohms for
6F catheters and greater than 100 ohms for 8F catheters. At
the end a completion duplex scan was obtained to assess
changes in the treated GSV and to document patency of the
common femoral, proximal femoral, and deep femoral
veins. Stab avulsion of prominent varicosities and subfascial
endoscopic perforator ligation were then performed when
indicated. After the procedure a woven elastic bandage
(Ace) was applied to the leg and thigh, and left in place for
48 hours in all patients. No limitations were placed on
mobilization, and patients were encouraged to walk as soon
as possible.
Follow-up duplex scans were obtained when the pa-
tients returned to the office (International Commission for
Accreditation of Vascular Laboratories accredited labora-
tory). The venous duplex scanning protocol included in-
sonation of infrainguinal veins, including infrapopliteal and
calf muscle veins, to rule out deep venous thrombosis
(DVT). Special attention was paid to scanning of the GSV
(occlusion, size, presence of clot) and its tributaries (pa-
tency of the inferior epigastric vein), and the saphenofemo-
ral junction, to ensure the absence of GSV thrombus ex-
tension.
Seventy-three lower extremities were treated in 66
patients with GSV reflux between April 2003 and February
2004. All patients underwent preoperative venous duplex
scanning of the lower extremities. In all patients in this
series the GSV was located greater than 5 mm from the skin
level, with reflux time greater than 500 ms and diameter
greater than 5 mm. There were 48 (73%) female patients
and 18 (27%) male patients, with ages ranging from 26 to
88 years (mean, 62  14 years).
The severity of venous insufficiency in all patients was
classified with CEAP guidelines. Two patients (3%) hadCEAP class 2 disease, 19 patients (26%) had class 3 disease,
28 patients (38%) had class 4 disease, 4 patients (6%) had
class 5 disease, and 20 patients (27%) had class 6 disease.23
Seven patients (10%) were taking aspirin preopera-
tively, 1 patient was receiving warfarin sodium (Coumadin)
therapy, and 1 patient was taking clopidogrel bisulfate
(Plavix). None of the patients in this series was known to
have a hypercoagulable state. Preadmission coagulation
workup was limited to prothrombin time, partial thrombo-
plastin time, and platelet count, which were normal in all
but 1 patient who had a low platelet count of 97,000/
mm3.
General anesthesia was administered in 32 (44%) pa-
tients, regional femoral block in 33 (45%) patients, and
local anesthetics with sedation in the remaining 8 (11%)
patients.
GSV diameter determined the size of RFA catheter
used. In veins smaller than 8 mm in diameter a 6F catheter
was used (54 cases), and in veins 8 mm or larger in diameter
an 8F catheter was used (19 cases).
RESULTS
Postoperative follow-up. All patients underwent fol-
low-up venous duplex scanning 2 to 30 days (mean, 10 6
days) after the procedure. These duplex scans documented
occlusion of the GSV in 70 (96%) patients; in the remaining
3 patients the GSV was not obliterated. One of these
patients underwent a successful repeat RFA procedure, 1
patient opted for operative stripping of the GSV, and the
remaining patient refused further treatment.
All patients with successful GSV closure (96%) were
satisfied with the procedure. Patients with combined RFA
and varicose vein excision had minor discomfort at the
surgical site. In 1 female patient a 5-mm long superficial
skin abrasion developed, which healed shortly after the
procedure.
Postoperative DVT. DVT was found in 12 limbs
(16%). Eleven of these patients had an extension of the
occlusive clot filling the treated proximal GSV segment as a
floating tail beyond the patent inferior epigastric vein into
the common femoral vein (CFV). In the other patient acute
occlusive clots developed in the calf muscle (gastrocne-
mius) veins in the treated limb. Eight patients were read-
mitted and received anticoagulation therapy. Four patients
were given enoxaparin on an ambulatory basis.
All 12 patients with DVT underwent at least 1 fol-
low-up duplex examination 3 to 14 days after the initial
diagnosis. None had clinical evidence of pulmonary embo-
lism. Ten of 11 patients with a CFV thrombus demon-
strated complete thrombus resolution after 5 to 14 days.
The remaining patient with calf muscle DVT demonstrated
no resolution of the thrombi after 2 weeks of anticoagula-
tion therapy.
Although we diagnosed acute free-floating thrombus
in the CFV (Fig) in 11 patients, only 3 underwent place-
ment of an inferior vena cava (IVC) filter. These were the
first 3 patients in whom we diagnosed such DVT after RFA
of the GSV. The fourth patient was offered an IVC filter,
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that the thrombus had completely resolved. In addition, all
3 patients in whom an IVC filter was inserted demonstrated
complete resolution of the CFV thrombus. On the basis of
this early experience we decided to initially follow a more
conservative approach with anticoagulation alone. If repeat
duplex scans after 1 week of anticoagulation therapy did
not result in resolution of the thrombus or adherence to the
vein wall an IVC filter was inserted (n  1).
DVT and patient demographic data. There was no
statistically significant difference in the incidence of post-
procedure DVT between male patients (2 of 18) and female
patients (10 of 48; P  .5). Similarly, we did not find a
statistically significant difference in age between patients in
whom DVT developed (mean age, 59  16 years) com-
pared with those in whom DVT did not develop (63  14
years; P  .4).
DVT and preoperative indications. CEAP classifica-
tion in patients with postoperative DVT (average, 4.3 
1.4) was not statistically different from that in patients with
an uneventful postoperative course (average, 4.3  1.2).
DVT and type of anesthesia. Post-procedure DVT
developed in 7 of 32 (22%) patients who received general
Free-floating commoanesthesia, compared with 5 of the remaining 41 (12%)
patients who received regional or local anesthesia (P .3).
DVT and catheter size. Of the 19 limbs treated with
the 8F RFA catheter, GSV clot extension developed in 5
(26%), compared with 7 of 54 (13%) limbs treated with the
6F RFA catheter (P  .3).
DVT and simultaneous varicose vein incision. No
difference was found between the occurrence of DVT in
patients who underwent the combined procedure (RFA
and varicose vein excision) compared with patients who
underwent GSV RFA only (P  .7).
DVT and postoperative mobilization. All patients
were ambulatory within the first 6 postoperative hours.
DISCUSSION
The concept of endoluminal treatment of insufficient
superficial veins is not new. Indeed, 5 decades ago investi-
gators reported the use of electrocoagulation to obliterate
enlarged greater and lesser saphenous veins.24 This ap-
proach was further modified by Watts25 and O’Reilly,26 but
was later abandoned because of a high incidence of nerve
injury and third-degree burns of the skin.
oral vein thrombus.n fem
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the most exciting advances in venous surgery, with the
potential to revolutionize the field. Randomized data ex-
amining this procedure compared with traditional open
stripping suggest that the Closure procedure is associated
with less postoperative pain, improved quality of life, faster
recovery, and significant cost savings as a result of fewer sick
days.21,22 Furthermore, some have suggested that patients
undergoing the Closure procedure may possibly be less
prone to neovascularization, because the saphenofemoral
junction is left intact.27,28
While any surgical procedure in patients with varicosi-
ties is associated with the risk for DVT, the frequency of
DVT has been reported to be quite low (about 1%) in the
largest reported series.21,29 However, duplex scanning in
these series was performed at various time points, some-
times with an unspecified percentage of patients actually
followed up and with unspecified protocols for duplex
scanning.21,22,29,30 If the thrombus extension is tempo-
rary, duplex scanning at 1 to 2 weeks after the procedure
may be too late to image thrombosis. Furthermore, most of
these reports have been supported by the manufacturers.
This has led to calls for rigorous, unbiased prospective
trials.
On the other hand, in 1 series not financially supported
by manufacturers, DVT developed in 2 of 29 (7%) patients
after the procedure.31 In this series the catheter was placed
via an incision in the groin and was passed down the vein.
One patient had popliteal vein DVT, and the other patient
had DVT of the treated extremity 6 weeks after the proce-
dure.
In addition, the FDA website (http://www.fda.gov/
medwatch/index.html) contains 24 reports of adverse out-
comes associated with the Closure procedure, 4 of which
include pulmonary embolism and 22 with DVT or ascend-
ing thrombosis.32 These may raise the issue of the true
incidence of DVT after closure, because it is suspected that
this may represent gross underreporting.33 These data sug-
gest that further study of the early effects of the Closure
procedure is necessary.
As a possible solution to this issue, a group of investi-
gators suggested the routine use of low molecular weight
heparin (LMWH) as thrombosis prophylaxis, because this
might prevent postoperative DVT.34 This suggestion is
intriguing, but not universally agreed on.
One of the main criticisms of the published data is the
limited follow-up in reports of the Closure registry.35
Long-term results for closure of the GSV are unknown,
because up to 2 years of follow-up with duplex scanning has
been documented in only a subset of the entire regis-
try.36,37 It is hoped that this issue can be further addressed
as more centers report their experience.
The question still remains as to how permanent the
Closure procedure is.35 Data from the VNUS Closure
Registry indicated that complete occlusion of the GSV is
seen in 93% of limbs at 1 week, 86% of limbs at 6 months,
83% of limbs at 12 months, and 85% of limbs at 24 months.
These results indicate that the percentage of durable saphe-nous vein occlusions appears to decrease over time and that
further examination is needed.29
While the goal of the Closure procedure is to denature
the collagen in the wall of the vein in a bloodless field with
no resultant thrombus, the actual result may not be so ideal.
We suspect that the combination of thrombosis, resorption
of thrombus, intimal damage, shrinkage, and denaturiza-
tion of the vein wall all probably contribute to the final
results of the Closure procedure. While thrombus in the
middle of the GSV with the denatured vein above and
below this area may still produce an adequate result, throm-
bus above or below the denatured vein and exposed to the
venous circulation is also a possibility. Indeed, some DVT
reported from the group supported by the manufacturer
described thrombus extension into the CFV. One of these
was a floating thrombus extending from the orifice of the
GSV in a patient with multiple post-procedure pulmonary
emboli.30
Possible causes of postoperative thrombosis with prop-
agation to the deep system in our patients include undiag-
nosed hypercoagulable states or local damage to the endo-
thelium from the catheter or electrodes despite careful
attempts to position the catheter and open electrodes in the
proximal GSV under direct visualization with duplex ultra-
sound guidance. It is also possible that thrombus may form
in the remaining GSV stump,27 and may propagate into the
CFV. If the vein went into spasm during the procedure as a
result of placement of the guide wire or catheter, or was
collapsed from the tumescence solution, it may appear to be
sealed at the end of the procedure. Later, when the spasm
reverses, the lumen may open and enable blood to enter an
area with damaged endothelium, with resultant thrombus
formation.
Several factors could potentially explain the higher
incidence of DVT in our patients. They were older and had
more severe venous stasis, compared with patients in other
series.21,29 In these studies mean patient age was less than
50 years, compared with 62 years in our series. Most of our
patients (75%) had CEAP class 4 disease, compared with
class 2 disease in at least 75% of patients in the other studies.
There is evidence in the literature that increased age is
associated with hypercoagulability.38,39 Although the Vir-
chow triad correlates venous stasis with thrombus forma-
tion, to our knowledge there are no published articles that
confirm the association of primary venous insufficiency
with hypercoagulability. Notwithstanding the probable
theories concerning the formation of thrombus with the
Closure procedure, further careful examination is needed.
Our experience suggests that early postoperative duplex
scanning is essential, and should be mandatory in all pa-
tients undergoing RFA of the GSV.
We thank Anne Ober for editorial assistance.
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